CME Group Buys CMA for OTC Data Play

The acquisition, which closed on Sunday, March 23, "diversifies the CME as a company, and gives us exposure to the large and fast-growing OTC derivatives market... [where] we can add value in terms of leveraging our technology and transaction processing capabilities," says a CME spokesperson.

CME participants "are looking for tools like [those of] CMA that help them make better trading decisions" in the credit markets, which remain relatively opaque, the spokesperson says. "This is another area